PMID: 9425332Jan 13, 1998Paper

Sentinel lymphadenectomy for patients with clinical stage I melanoma

Journal of Surgical Oncology
D Morton

Abstract

Consistent results with SLND can only be obtained through the combined efforts of the nuclear medicine physician, the surgeon, and the pathologist. These individuals must have experience with the technical details of SLND and must understand and accept the multidisciplinary nature of this technique. The reports in this issue of the Journal of Surgical Oncology prove that SLND is accurate and reproducible. Drs. Thompson and Karakousis both report a 93% rate of sentinel node identification, and Dr. Reintgen reports a rate of 96%. At JWCI, our overall rate of sentinel node identification has now reached 98%. The ultimate results of SLND as a therapeutic procedure in patients with clinical stage I cutaneous melanoma await completion of our international phase III multicenter trial ("A Clinical Study of Wide Excision Alone Versus Wide Excision with Intraoperative Lymphatic Mapping and Selective Lymph Node Dissection in the Treatment of Patients with Cutaneous Invasive Melanoma"; D.L. Morton, Principal Investigator), which is now in its third year of accrual. At the present time, we believe that lymphatic mapping and selective (sentinel) lymph node dissection is an investigational procedure whose therapeutic utility is unproven. Unti...Continue Reading

References

Sep 22, 1977·The New England Journal of Medicine·U VeronesiN N Trapeznikov
Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Dec 1, 1991·Archives of Surgery·R HellerD S Reintgen
Jun 1, 1995·Archives of Surgery·D N KragJ C Alex
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D S HoonD L Morton
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L MortonA Cochran
Feb 8, 1996·International Journal of Cancer. Journal International Du Cancer·F DoiD S Hoon
Jul 1, 1996·The American Journal of Surgical Pathology·K F CarsonA J Cochran

❮ Previous
Next ❯

Citations

Jan 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L KretschmerH Starz
Jun 30, 2000·BMJ : British Medical Journal·J M Thomas, E J Patocskai
Sep 12, 2013·Actas dermo-sifiliográficas·L Mahiques SantosV Alegre de Miquel
Jan 15, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·P VereeckenM Heenen
May 20, 2008·Seminars in Cutaneous Medicine and Surgery·Monika-Hildegard Schmid-Wendtner, Dorothee Dill-Müller
May 26, 2009·Hematology/oncology Clinics of North America·Adriano Piris, Martin C Mihm
Oct 13, 2006·Annales de chirurgie plastique et esthétique·A LavieG Magalon
Jun 11, 2004·Seminars in Oncology·Katherine E PostherArmando E Giuliano
Mar 15, 2005·Seminars in Nuclear Medicine·Ronald N KaleyaJonathan S Zager
Sep 23, 2000·British Journal of Plastic Surgery·S P HettiaratchyB W Powell
Jan 25, 2000·Cancer Treatment Reviews·A J BremersC J van de Velde
Aug 28, 2001·Seminars in Surgical Oncology·P J van DiestC J Meijer
Aug 23, 2002·Clinical Nuclear Medicine·Maile J SeraJan H Wong
May 6, 2005·Journal of Lower Genital Tract Disease·Mary Ellen WechterTimothy M Johnson
Dec 2, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Andreas BlumDorothee Dill-Müller
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PalmieriUNKNOWN Melanoma Cooperative Group
Oct 2, 2007·Mund-, Kiefer- und Gesichtschirurgie : MKG·Karin LinkeschovaHarald Eufinger
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Oct 20, 2001·Ophthalmic Plastic and Reconstructive Surgery·M W WilsonB G Haik
May 6, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Omgo E NiewegCornelis A Hoefnagel
Jan 5, 2001·The Surgical Clinics of North America·J H Wong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.